Clinical Trials Directory

Trials / Unknown

UnknownNCT03676608

Use of Bee Wax Mammary Areolae to Improve Breastfeeding

Study of Health Education to Improve Adherence to Breastfeeding in Primiparous Women Through the Use of Bee Wax Mammary Areolae

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
University of Alicante · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

A comparative randomized intervention study is presented between a mixed strategy of use of bee wax mammary areolae. Together with the health education program for the promotion of breastfeeding by the WHO and another educational program with the aim of improving the adherence of breastfeeding to primiparous women. The use of both interventions can contribute to the adherence to exclusive maternity in 20% in the first 6 months of life, than only with the educational program. The study provides evidence of nursing practice, thus contributing to the improvement of nursing mothers in the prevention of lesions in the nipple and care in them if they occur. Consequently, improve the rates of successful breastfeeding, as well as the quality of life of breastfeeding mothers. The study will be carried out with several groups of midwives in Health Centers, in Spain, Colombia and Mexico. The sample was calculated in 240 women who attend the midwife's controls between week 29 and 40.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBee Wax Mammary AreolaeThe product to be valued are mammary areolae made by hand with organic beeswax. Despite its honey aroma, it does not contain honey. The wax used for the manufacture of the areolae is operculum. This wax is used and not another because it avoids possible residues and allergies that may contain other types of waxes. The operculum wax is used as a thickener in pharmacy and cosmetic products as a fat base in ointments and creams.
OTHERUsual educational careThe WHO protocol for maternal lactation.

Timeline

Start date
2018-06-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-09-18
Last updated
2018-09-18

Locations

3 sites across 3 countries: Colombia, Mexico, Spain

Source: ClinicalTrials.gov record NCT03676608. Inclusion in this directory is not an endorsement.